By John George – Senior Reporter, Philadelphia Business Journal Virpax Pharmaceuticals Inc. has joined the battle against Covid-19 through a new technology licensing agreement with a London life sciences company. The Chester County drug developer signed the deal [...]

This article from Life Science Leader magazine features the views of top executives, including Virpax's CEO Anthony Mack, on how the life sciences industry business model meets public health obligations. Read more on lifescienceleader.com [...]

Virpax Pharmaceuticals has licensed MedPharm’s topical spray technology to develop a transdermal patch for non-opioid pain management products. Read more on in-pharmatechnologist.com